We are delighted by today's decision to allow patients with advanced prostate cancer to receive abiraterone on the NHS.
This drug was discovered at the Institute of Cancer Research and is the result of more than two decades of dedicated work by our scientists and and collaborators.
In clinical trials of men with advanced prostate cancer who have already tried chemotherapy, it has been shown to extend life by an average of four months and improve quality of life.
More top news
The prime minister said there was a "clear and urgent imperative" to give new impetus to stalled negotiations.
Pollution claimed nine million lives in 2015, with air pollution from vehicles and factories accounting for 6.5m deaths, researchers found.
Donald Trump has given himself a "10 out of 10" for the response to the widespread hurricane devastation Puerto Rico suffered.